Login / Signup

hTERT Gene Modification Using CRISPR-dCas9-dnmt3a System as a Therapeutic Approach Against Glioma.

Farbod Taghavi RadSaied GhorbianBahar Naghavi GargariZeinab Shirvani FarsaniRasoul Sharifi
Published in: Iranian journal of pharmaceutical research : IJPR (2023)
expression and telomerase activity and thus inhibit glioma cell growth.
Keyphrases
  • genome wide
  • dna methylation
  • poor prognosis
  • crispr cas
  • genome editing
  • binding protein
  • gene expression
  • long non coding rna
  • transcription factor